Armenia will start vaccination of girls at the age of 13 from  papillomavirus from December 2017

ArmInfo.Armenia will start vaccination of girls at the age of 13 from virus papilla  December 2017 to prevent cervical cancer. The decision on this was taken at a  government meeting on November 9.As the Armenian Minister of Health Levon Altunyan stated, starting from the second decade of December of this year to the middle of 2018, vaccination will be carried out.

It consists of 2 doses and will be conducted with a difference of six months. According to the minister, the scheme is consonant with the official position of the World Health Organization (WHO), according to which the planned vaccination is offered to girls aged 9-14 years.  According to Altunian, in Armenia in the structure of cancer in  women, cervical cancer is in second place after breast cancer. In  Armenia, 250-300 new cases of cervical cancer are diagnosed each  year, the concern is that the disease is detected at a late stage. 

"About 100-130 women die each year from this disease," he said,  adding that in 2007 127 cases were registered (8.1 per mille), and in  2016 116 (7.4 per mille). Meanwhile, for example, in Finland, this  figure is 1-1.2 ppm. Vaccination against human papilla virus, as  stated by the head of the Ministry of Health, has high productivity.  It will be possible to refuse from it only under the receipt of the  parents. However, as the minister pointed out, even 1 dose of the  vaccine forms antibodies in 80-85% of cases, which is considered an  indicator of high productivity.At present, within the framework of  the grant program, Armenia has received 32,400 doses of gardasil  (tetravalent vaccine). It is planned to vaccinate 16 thousand girls  at the age of 13 years. The cost of the vaccine for Armenia is $ 4.5,  while the market value of the drug is $ 100.

As the head of the Yerevan office of the World Health Organization  Egor Zaitsev stated earlier at the press conference, the initiative  The Ministry of Health on mandatory vaccination against the human  papillA virus is very relevant. Zaitsev noted that the World Health  Organization actively supports this initiative of the Ministry of  Health of Armenia. "Vaccination is carried out in more than 70  countries around the world, including in Europe, such as the United  Kingdom, Denmark, the Netherlands, Portugal, and also in the US,  Canada and Australia." In all of the above countries, vaccination has  positive effects. will be carried out by girls between the ages of 9  and 13 with the consent of the children and their parents, since at  this age children do not yet have a sex life, the effectiveness of  vaccination will be much higher, "Zaitsev explained.  WHO expert,  Professor Paul Blum, in turn, noted that, although the vaccine is  relatively new, and it is too early to talk about its 100%  effectiveness, however, according to preliminary data, in countries  where this type of vaccination is practiced, a sharp reduction of  infection with papillomavirus. In turn, the expert, a professor from  Sweden Joachim Dilner noted that over the past 10 years, the World  Health Organization has studied the safety of the vaccine, and in  June 2017 it was proved that the vaccine is absolutely safe for  humans. According to him, this vaccine as a whole increases immunity,  which also positively affects human health. As noted by the doctor of  medical sciences, professor, cancer specialist Gagik Bazikyan, in the  US, vaccination against the papilla virus of the girl takes place at  the age of 17 to 27 years, and, as practice shows, women subsequently  do not have any problems with reproduction. "So the parents' concerns  about further reproductive problems are groundless," Bazikyan  assured